Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Darifenacin hydrobromide

Darifenacin hydrobromide

pharmaceutical raw materials
Darifenacin hydrobromide structure

Darifenacin hydrobromide 

structure
  • CAS No:

    133099-07-7

  • Formula:

    C28H30N2O2.BrH

  • Chemical Name:

    Darifenacin hydrobromide

  • Synonyms:

    3-Pyrrolidineacetamide,1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-,hydrobromide (1:1),(3S)-;3-Pyrrolidineacetamide,1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-,monohydrobromide,(S)-;3-Pyrrolidineacetamide,1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-,monohydrobromide,(3S)-;UK 88525-04;Darifenacin hydrobromide;UK 88525-04 hydrobromide;Enablex;Emselex;(S)-3-(Carbamoyldiphenylmethyl)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidine hydrobromide;Darilong;2-[(3S)-1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide hydrobromide

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

White SolidChEBI: The hydrobromide salt of darifenacin. A selective antagonist for the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions, it is used in the management of urinary incontinence.Darfenacin (Enablex),(s)-2-{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphen-ylacetamide, is an antimuscarinicagent that has selectivity for the M3 muscarinicsubtype receptor. By competitively blocking of the muscarinicreceptors results i


Darifenacin hydrobromide is the hydrobromide salt of darifenacin. A selective antagonist for the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions, it is used in the management of urinary incontinence. It has a role as a muscarinic antagonist. It contains a darifenacin.

Darifenacin hydrobromide Basic Attributes

505.44606

506.15689

1308068-626-2

CR02EYQ8GV

DTXSID9046780

G04BD10

2934990002

Characteristics

55.6

5.94630

white to beige

228-2300C

614.3°C at 760 mmHg

325.3ºC

DMSO: soluble20mg/mL, clear

-20°C Freezer

1.11E-16mmHg at 25°C

25D -30.3° (c = 1.0 in methylene chloride)

Safety Information

NONH for all modes of transport

3

P261-P305 + P351 + P338

H315-H319-H335

|Warning|H315 (95.12%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 41 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with overactive bladder syndrome.

Drugs used in the treatment of urogenital conditions and diseases such as URINARY INCONTINENCE; PROSTATIC HYPERPLASIA; and ERECTILE DYSFUNCTION. (See all compounds classified as Urological Agents.)|Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)

(S)-1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide

Darifenacin hydrobromide Use and Manufacturing

Uses

acute lymphoblastic leukemia therapeutic

Human drugs -> Emselex -> EMA Drug Category|Urologicals, Drugs for urinary frequency and incontinence -> Human pharmacotherapeutic group|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:507.5
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:7
Exact Mass:506.15689
Monoisotopic Mass:506.15689
Topological Polar Surface Area:55.6
Heavy Atom Count:33
Complexity:607
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Recommended Suppliers of Darifenacin hydrobromide

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.